| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |